Test Bank Complete_
Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition, (2025)
By Linda E. Mccuistion, Kathleen Vuljoin Dimaggio, Mary B. Winton & Jennifer J. Yeager
All Chapters 1-58| 18 Units| Latest Edition With Well Detailed Answers| Grade A+
From: [Bestmaxsolutions.Stuvia
,UNIT I: INTRODUCTION TO PHARMACOLOGY ---------------------------------------------------------------- 5
Chapter 01: Clinical Judgment Measurement Model And The Nursing Process -----------------------------5
Chapter 02: Drug Development And Ethical Considerations ---------------------------------------------------- 19
Chapter 03: Pharmacokinetics And Pharmacodynamics --------------------------------------------------------- 35
Chapter 04: Pharmacogenetics ----------------------------------------------------------------------------------------- 65
Chapter 05: Complementary And Alternative Therapies -------------------------------------------------------- 72
Chapter 06: Pediatric Considerations --------------------------------------------------------------------------------- 84
Chapter 07: Geriatric Considerations --------------------------------------------------------------------------------- 98
Chapter 08: Drugs In Substance Use Disorder -------------------------------------------------------------------- 110
UNIT II: PHARMACOTHERAPY AND DRUG ADMINISTRATION ---------------------------------------- 121
Chapter 09: Safety And Quality --------------------------------------------------------------------------------------- 121
Chapter 10: Drug Administration ------------------------------------------------------------------------------------ 134
Chapter 11: Drug Labels And Dosage Calculations -------------------------------------------------------------- 145
UNIT III: MAINTENANCE OF HOMEOSTASIS --------------------------------------------------------------- 158
Chapter 12: Fluid Volume And Electrolytes ----------------------------------------------------------------------- 158
Chapter 13: Vitamin And Mineral Replacement ----------------------------------------------------------------- 177
Chapter 14: Nutritional Support-------------------------------------------------------------------------------------- 192
UNIT IV: AUTONOMIC NERVOUS SYSTEM DRUGS ------------------------------------------------------- 208
Chapter 15: Adrenergic Agonists And Antagonists -------------------------------------------------------------- 208
Chapter 16: Cholinergic Agonists And Antagonists -------------------------------------------------------------- 220
UNIT V: CENTRAL AND PERIPHERAL NERVOUS SYSTEM DRUGS ------------------------------------- 233
Chapter 17: Stimulants ------------------------------------------------------------------------------------------------- 233
Chapter 18: Depressants ----------------------------------------------------------------------------------------------- 242
Chapter 19: Antiseizure Drugs ---------------------------------------------------------------------------------------- 259
Chapter 20: Drugs For Parkinson Disease And Alzheimer Disease ------------------------------------------ 274
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ------------------------------------- 288
UNIT VI: MENTAL AND BEHAVIORAL HEALTH DRUGS -------------------------------------------------- 301
Chapter 22: Antipsychotics And Anxiolytics ----------------------------------------------------------------------- 301
Chapter 23: Antidepressants And Mood Stabilizers------------------------------------------------------------- 316
UNIT VII: PAIN AND INFLAMMATION MANAGEMENT DRUGS --------------------------------------- 331
Chapter 24: Antiinflammatories -------------------------------------------------------------------------------------- 331
, Chapter 25: Analgesics -------------------------------------------------------------------------------------------------- 346
UNIT VIII: ANTIMICROBIAL DRUGS -------------------------------------------------------------------------- 360
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins ------------------------------------------ 360
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides
-------------------------------------------------------------------------------------------------------------------------------- 376
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ------------------- 391
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics -------------------------------------------------- 403
Chapter 30: Antituberculars, Antifungals, And Antivirals ----------------------------------------------------- 451
Chapter 31: Antimalarials, Anthelmintics, And Peptides ------------------------------------------------------ 469
UNIT IX: IMMUNOLOGIC DRUGS ----------------------------------------------------------------------------- 476
Chapter 32: Hiv- And Aids-Related Drugs -------------------------------------------------------------------------- 476
Chapter 33: Transplant Drugs ----------------------------------------------------------------------------------------- 485
Chapter 34: Vaccines ---------------------------------------------------------------------------------------------------- 491
UNIT X: ANTINEOPLASTICS AND BIOLOGIC RESPONSE MODIFIERS --------------------------------- 500
Chapter 35: Anticancer Drugs ----------------------------------------------------------------------------------------- 500
Chapter 36: Targeted Therapies To Treat Cancer ---------------------------------------------------------------- 509
Chapter 37: Biologic Response Modifiers -------------------------------------------------------------------------- 516
UNIT XI: RESPIRATORY DRUGS ------------------------------------------------------------------------------- 525
Chapter 38: Upper Respiratory Disorders -------------------------------------------------------------------------- 525
Chapter 39: Lower Respiratory Disorders -------------------------------------------------------------------------- 534
UNIT XII: CARDIOVASCULAR DRUGS ------------------------------------------------------------------------ 551
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ------------------------------------- 551
Chapter 41: Diuretics ---------------------------------------------------------------------------------------------------- 567
Chapter 42: Antihypertensives --------------------------------------------------------------------------------------- 576
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics ---------------------------------------------- 589
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ------------------------ 604
UNIT XIII: GASTROINTESTINAL DRUGS---------------------------------------------------------------------- 615
Chapter 45: Gastrointestinal Tract Disorders --------------------------------------------------------------------- 615
Chapter 46: Antiulcer Drugs ------------------------------------------------------------------------------------------- 629
UNIT XIV: EYE, EAR, AND SKIN DRUGS ---------------------------------------------------------------------- 641
Chapter 47: Eye And Ear Disorders ---------------------------------------------------------------------------------- 641
, Chapter 48: Dermatologic Disorders -------------------------------------------------------------------------------- 649
UNIT XV: ENDOCRINE DRUGS --------------------------------------------------------------------------------- 658
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders --------------------------------------- 658
Chapter 50: Antidiabetics ---------------------------------------------------------------------------------------------- 674
UNIT XVI: RENAL AND UROLOGIC DRUGS ----------------------------------------------------------------- 689
Chapter 51: Urinary Disorders ---------------------------------------------------------------------------------------- 689
UNIT XVII: REPRODUCTIVE AND GENDER-RELATED DRUGS------------------------------------------- 700
Chapter 52: Pregnancy And Preterm Labor------------------------------------------------------------------------ 700
Chapter 53: Labor, Delivery, And Postpartum -------------------------------------------------------------------- 714
Chapter 54: Neonatal And Newborn -------------------------------------------------------------------------------- 725
Chapter 55: Women’s Reproductive Health ----------------------------------------------------------------------- 729
Chapter 56: Men’s Reproductive Health --------------------------------------------------------------------------- 742
Chapter 57: Sexually Transmitted Infections---------------------------------------------------------------------- 751
UNIT XVIII: EMERGENCY DRUGS ----------------------------------------------------------------------------- 757
Chapter 58: Adult And Pediatric Emergency Drugs -------------------------------------------------------------- 757
,UNIT I: INTRODUCTION TO PHARMACOLOGY
Chapter 01: Clinical Judgment Measurement Model And The Nursing Process
Linda E. McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition, (2025) Test Bank
MULTIPLE CHOICE
1. During A Medication Review Session, A Patient States, " I Do Not Know Why I Am
Taking All Of These Pills. " Based On This Piece Of Subjective Data, Which Problem
Will The Nurse Identify?
A. Pain
B. Knowledge
C. Fatigue
D. Anxiety
ANS: B.
This Patient's Statement Indicates A Lack Of Understanding About Their Medication
Regimen, Pointing To A Knowledge Deficit. While Fatigue, Pain, Or Anxiety Could Be
Present, The Most Relevant And Specific Issue Reflected By The Patient’s Words Is A
Lack Of Knowledge About The Purpose Of Their Medications. Addressing This Will
Improve Adherence And Safety.
Dif: Cognitive Level: Subjective Data Interpretation) Top: Nursing Process:
Planningmsc: Nclex: Management Of Care
2. The Nurse Is Developing A List Of The Patient's Expected Outcomes. Which Is The
Best Expected Outcome For This Patient?
A. The Patient Will Self - Administer Albuterol By Taking A Deep Breath Before
Inhaling.
B. The Patient Will Self - Administer Albuterol By The End Of The Sec Ond Teaching
Session
,C. The Patient Will Independently Self - Administer The Prescribed Dose Of Albuterol
By The End Of The Second Teaching Session.
D. The Patient Will Organize Their Medications According To The Time Each
Medication Is Due.
ANS: C.
This Outcome Is Specific, Measurable, Achievable, Realistic, And Time-Bound (Smart).
It Clearly Defines What The Patient Is Expected To Do, How It Will Be Assessed, And
When It Should Be Achieved. Option C Incorporates Both Independence And Correct
Technique, Which Are Essential Goals In Patient Education.
Dif: Cognitive Level: Effective Expected Outcome) Top: Nursing Process: Planningmsc:
Nclex: Management Of Care
3. When Developing An Effective Medication Teaching Plan, Which Component Will
The Nurse Identify As Most Essential?
A. Written Instructions
B. The Patient's Readiness To Learn
C. Use Of Colorful Charts
D. A Review Of Community Resources
ANS: B.
No Teaching Will Be Effective If The Patient Is Not Mentally, Emotionally, Or
Physically Ready To Engage In The Learning Process. Readiness To Learn Is The
Foundation For Successful Education, As It Determines How Much Information The
Patient Can Process And Apply.
Dif: Cognitive Level: Component of Teaching Plan) Top: Nursing Process: Planningmsc:
Nclex: Management Of Care
, 4. When Developing An Individualized Medication Teaching Plan, Which Topics Will
The Nurse Include? (Select All That Apply.)
A. Adherence To The Prescribed Drug Regimen
B. Always Using The Prescribed Drug Route
C. Knowing Adverse Side Effects To Report To Doctord.
D. Always Doubling The Next Dose If Drug Is Missed
E. Telling The Doctor When Taking Over - The - Counter (Otc) Supplements
ANS: A, B, C, E
A. Adherence Ensures Effectiveness And Safety Of Treatment.
B. Correct Routes Are Crucial For Drug Absorption And Effect.
C. Patients Should Know What Adverse Reactions Need Immediate Reporting.
E. Otc Supplements May Interact With Prescribed Medications, So The Provider Must Be
Informed.
D. Doubling A Dose After Missing One Is Dangerous And Not Recommended.
Dif: Cognitive Level: Understanding (Comprehension) Top: Nursing Process:
Planningmsc: Nclex: Management Of Care
5. The Nursing Alliance For Quality Care's Main Focus Is For Health Care Providers To
Strive For Which Goal?
A. Quality In Medication Administration
B. Confidentiality As Determined By The Patient
C. Development Of A Patient Relationship / Family Engagement
D. Patient Independence Within The Family Of Origin
ANS: C.
The Alliance Promotes Person-Centered Care, Where The Nurse Builds Collaborative
Relationships With Patients And Families. This Improves Communication, Shared
Decision-Making, And Patient Safety.
Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition, (2025)
By Linda E. Mccuistion, Kathleen Vuljoin Dimaggio, Mary B. Winton & Jennifer J. Yeager
All Chapters 1-58| 18 Units| Latest Edition With Well Detailed Answers| Grade A+
From: [Bestmaxsolutions.Stuvia
,UNIT I: INTRODUCTION TO PHARMACOLOGY ---------------------------------------------------------------- 5
Chapter 01: Clinical Judgment Measurement Model And The Nursing Process -----------------------------5
Chapter 02: Drug Development And Ethical Considerations ---------------------------------------------------- 19
Chapter 03: Pharmacokinetics And Pharmacodynamics --------------------------------------------------------- 35
Chapter 04: Pharmacogenetics ----------------------------------------------------------------------------------------- 65
Chapter 05: Complementary And Alternative Therapies -------------------------------------------------------- 72
Chapter 06: Pediatric Considerations --------------------------------------------------------------------------------- 84
Chapter 07: Geriatric Considerations --------------------------------------------------------------------------------- 98
Chapter 08: Drugs In Substance Use Disorder -------------------------------------------------------------------- 110
UNIT II: PHARMACOTHERAPY AND DRUG ADMINISTRATION ---------------------------------------- 121
Chapter 09: Safety And Quality --------------------------------------------------------------------------------------- 121
Chapter 10: Drug Administration ------------------------------------------------------------------------------------ 134
Chapter 11: Drug Labels And Dosage Calculations -------------------------------------------------------------- 145
UNIT III: MAINTENANCE OF HOMEOSTASIS --------------------------------------------------------------- 158
Chapter 12: Fluid Volume And Electrolytes ----------------------------------------------------------------------- 158
Chapter 13: Vitamin And Mineral Replacement ----------------------------------------------------------------- 177
Chapter 14: Nutritional Support-------------------------------------------------------------------------------------- 192
UNIT IV: AUTONOMIC NERVOUS SYSTEM DRUGS ------------------------------------------------------- 208
Chapter 15: Adrenergic Agonists And Antagonists -------------------------------------------------------------- 208
Chapter 16: Cholinergic Agonists And Antagonists -------------------------------------------------------------- 220
UNIT V: CENTRAL AND PERIPHERAL NERVOUS SYSTEM DRUGS ------------------------------------- 233
Chapter 17: Stimulants ------------------------------------------------------------------------------------------------- 233
Chapter 18: Depressants ----------------------------------------------------------------------------------------------- 242
Chapter 19: Antiseizure Drugs ---------------------------------------------------------------------------------------- 259
Chapter 20: Drugs For Parkinson Disease And Alzheimer Disease ------------------------------------------ 274
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ------------------------------------- 288
UNIT VI: MENTAL AND BEHAVIORAL HEALTH DRUGS -------------------------------------------------- 301
Chapter 22: Antipsychotics And Anxiolytics ----------------------------------------------------------------------- 301
Chapter 23: Antidepressants And Mood Stabilizers------------------------------------------------------------- 316
UNIT VII: PAIN AND INFLAMMATION MANAGEMENT DRUGS --------------------------------------- 331
Chapter 24: Antiinflammatories -------------------------------------------------------------------------------------- 331
, Chapter 25: Analgesics -------------------------------------------------------------------------------------------------- 346
UNIT VIII: ANTIMICROBIAL DRUGS -------------------------------------------------------------------------- 360
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins ------------------------------------------ 360
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides
-------------------------------------------------------------------------------------------------------------------------------- 376
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ------------------- 391
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics -------------------------------------------------- 403
Chapter 30: Antituberculars, Antifungals, And Antivirals ----------------------------------------------------- 451
Chapter 31: Antimalarials, Anthelmintics, And Peptides ------------------------------------------------------ 469
UNIT IX: IMMUNOLOGIC DRUGS ----------------------------------------------------------------------------- 476
Chapter 32: Hiv- And Aids-Related Drugs -------------------------------------------------------------------------- 476
Chapter 33: Transplant Drugs ----------------------------------------------------------------------------------------- 485
Chapter 34: Vaccines ---------------------------------------------------------------------------------------------------- 491
UNIT X: ANTINEOPLASTICS AND BIOLOGIC RESPONSE MODIFIERS --------------------------------- 500
Chapter 35: Anticancer Drugs ----------------------------------------------------------------------------------------- 500
Chapter 36: Targeted Therapies To Treat Cancer ---------------------------------------------------------------- 509
Chapter 37: Biologic Response Modifiers -------------------------------------------------------------------------- 516
UNIT XI: RESPIRATORY DRUGS ------------------------------------------------------------------------------- 525
Chapter 38: Upper Respiratory Disorders -------------------------------------------------------------------------- 525
Chapter 39: Lower Respiratory Disorders -------------------------------------------------------------------------- 534
UNIT XII: CARDIOVASCULAR DRUGS ------------------------------------------------------------------------ 551
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics ------------------------------------- 551
Chapter 41: Diuretics ---------------------------------------------------------------------------------------------------- 567
Chapter 42: Antihypertensives --------------------------------------------------------------------------------------- 576
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics ---------------------------------------------- 589
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ------------------------ 604
UNIT XIII: GASTROINTESTINAL DRUGS---------------------------------------------------------------------- 615
Chapter 45: Gastrointestinal Tract Disorders --------------------------------------------------------------------- 615
Chapter 46: Antiulcer Drugs ------------------------------------------------------------------------------------------- 629
UNIT XIV: EYE, EAR, AND SKIN DRUGS ---------------------------------------------------------------------- 641
Chapter 47: Eye And Ear Disorders ---------------------------------------------------------------------------------- 641
, Chapter 48: Dermatologic Disorders -------------------------------------------------------------------------------- 649
UNIT XV: ENDOCRINE DRUGS --------------------------------------------------------------------------------- 658
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders --------------------------------------- 658
Chapter 50: Antidiabetics ---------------------------------------------------------------------------------------------- 674
UNIT XVI: RENAL AND UROLOGIC DRUGS ----------------------------------------------------------------- 689
Chapter 51: Urinary Disorders ---------------------------------------------------------------------------------------- 689
UNIT XVII: REPRODUCTIVE AND GENDER-RELATED DRUGS------------------------------------------- 700
Chapter 52: Pregnancy And Preterm Labor------------------------------------------------------------------------ 700
Chapter 53: Labor, Delivery, And Postpartum -------------------------------------------------------------------- 714
Chapter 54: Neonatal And Newborn -------------------------------------------------------------------------------- 725
Chapter 55: Women’s Reproductive Health ----------------------------------------------------------------------- 729
Chapter 56: Men’s Reproductive Health --------------------------------------------------------------------------- 742
Chapter 57: Sexually Transmitted Infections---------------------------------------------------------------------- 751
UNIT XVIII: EMERGENCY DRUGS ----------------------------------------------------------------------------- 757
Chapter 58: Adult And Pediatric Emergency Drugs -------------------------------------------------------------- 757
,UNIT I: INTRODUCTION TO PHARMACOLOGY
Chapter 01: Clinical Judgment Measurement Model And The Nursing Process
Linda E. McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition, (2025) Test Bank
MULTIPLE CHOICE
1. During A Medication Review Session, A Patient States, " I Do Not Know Why I Am
Taking All Of These Pills. " Based On This Piece Of Subjective Data, Which Problem
Will The Nurse Identify?
A. Pain
B. Knowledge
C. Fatigue
D. Anxiety
ANS: B.
This Patient's Statement Indicates A Lack Of Understanding About Their Medication
Regimen, Pointing To A Knowledge Deficit. While Fatigue, Pain, Or Anxiety Could Be
Present, The Most Relevant And Specific Issue Reflected By The Patient’s Words Is A
Lack Of Knowledge About The Purpose Of Their Medications. Addressing This Will
Improve Adherence And Safety.
Dif: Cognitive Level: Subjective Data Interpretation) Top: Nursing Process:
Planningmsc: Nclex: Management Of Care
2. The Nurse Is Developing A List Of The Patient's Expected Outcomes. Which Is The
Best Expected Outcome For This Patient?
A. The Patient Will Self - Administer Albuterol By Taking A Deep Breath Before
Inhaling.
B. The Patient Will Self - Administer Albuterol By The End Of The Sec Ond Teaching
Session
,C. The Patient Will Independently Self - Administer The Prescribed Dose Of Albuterol
By The End Of The Second Teaching Session.
D. The Patient Will Organize Their Medications According To The Time Each
Medication Is Due.
ANS: C.
This Outcome Is Specific, Measurable, Achievable, Realistic, And Time-Bound (Smart).
It Clearly Defines What The Patient Is Expected To Do, How It Will Be Assessed, And
When It Should Be Achieved. Option C Incorporates Both Independence And Correct
Technique, Which Are Essential Goals In Patient Education.
Dif: Cognitive Level: Effective Expected Outcome) Top: Nursing Process: Planningmsc:
Nclex: Management Of Care
3. When Developing An Effective Medication Teaching Plan, Which Component Will
The Nurse Identify As Most Essential?
A. Written Instructions
B. The Patient's Readiness To Learn
C. Use Of Colorful Charts
D. A Review Of Community Resources
ANS: B.
No Teaching Will Be Effective If The Patient Is Not Mentally, Emotionally, Or
Physically Ready To Engage In The Learning Process. Readiness To Learn Is The
Foundation For Successful Education, As It Determines How Much Information The
Patient Can Process And Apply.
Dif: Cognitive Level: Component of Teaching Plan) Top: Nursing Process: Planningmsc:
Nclex: Management Of Care
, 4. When Developing An Individualized Medication Teaching Plan, Which Topics Will
The Nurse Include? (Select All That Apply.)
A. Adherence To The Prescribed Drug Regimen
B. Always Using The Prescribed Drug Route
C. Knowing Adverse Side Effects To Report To Doctord.
D. Always Doubling The Next Dose If Drug Is Missed
E. Telling The Doctor When Taking Over - The - Counter (Otc) Supplements
ANS: A, B, C, E
A. Adherence Ensures Effectiveness And Safety Of Treatment.
B. Correct Routes Are Crucial For Drug Absorption And Effect.
C. Patients Should Know What Adverse Reactions Need Immediate Reporting.
E. Otc Supplements May Interact With Prescribed Medications, So The Provider Must Be
Informed.
D. Doubling A Dose After Missing One Is Dangerous And Not Recommended.
Dif: Cognitive Level: Understanding (Comprehension) Top: Nursing Process:
Planningmsc: Nclex: Management Of Care
5. The Nursing Alliance For Quality Care's Main Focus Is For Health Care Providers To
Strive For Which Goal?
A. Quality In Medication Administration
B. Confidentiality As Determined By The Patient
C. Development Of A Patient Relationship / Family Engagement
D. Patient Independence Within The Family Of Origin
ANS: C.
The Alliance Promotes Person-Centered Care, Where The Nurse Builds Collaborative
Relationships With Patients And Families. This Improves Communication, Shared
Decision-Making, And Patient Safety.
